4 research outputs found

    Time to virological failure and treatment failure through the long term follow-up.

    No full text
    <p>Virological failure was defined as two consecutive measurements of pVL >50 copies/mL. Treatment failure included subjects with virological failure, treatment discontinuations due to drug toxicity, and death.</p

    Factors associated with virologic failure to a switch regimen composed of NVP plus TDF plus FTC (or 3TC) (n = 341).

    No full text
    <p>* Some individuals in early calendar years had an undetectable viral load at baseline, but with tests using a threshold of 80 or 200 copies/mL.</p><p>VL: viral load; VF: virologic failures; NNRTI: non-nucleoside reverse transcriptase inhibitor; NRTI: nucleoside analogue reverse transcriptase inhibitor; PI: protease inhibitor.</p><p>Factors associated with virologic failure to a switch regimen composed of NVP plus TDF plus FTC (or 3TC) (n = 341).</p

    Patient characteristics at the initiation of NVP plus TDF plus FTC (or 3TC) as a switch strategy (n = 341).

    No full text
    <p>Data are median (IQR) or n (%).</p><p>* Some individuals in the early calendar years had an undetectable viral load at baseline, but with tests using at that moment a threshold of 80 or 200 copies/mL.</p><p>MSM: Men having sex with men; NRTI: Nucleos(t)ide reverse transcriptase inhibitor; NNRTI: non-nucleoside reverse transcriptase inhibitor; PI: Protease inhibitor.</p><p>Patient characteristics at the initiation of NVP plus TDF plus FTC (or 3TC) as a switch strategy (n = 341).</p
    corecore